AIM: To investigate the biological role of alpha fetoprotein (AFP) and its clinical significance
in carcinogenesis of hepatocellular carcinoma (HCC). METHODS: Clinical analysis of HCC …

BACKGROUND α‐Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …

Background: Post-treatment alpha-fetoprotein (AFP) response has been reported to be
associated with prognosis of hepatocellular carcinoma (HCC) patients, but the results were …

Background Serum α‐fetoprotein (AFP) is the most important tumor marker for
hepatocellular carcinoma (HCC). The reported predictive accuracy of AFP for HCC widely …

Background This study evaluates the efficacy of alpha-fetoprotein (AFP) response as a
surrogate marker for determining recurrence-free survival (RFS) in patients with …

Abstract Background Alpha-1-fetoprotein (AFP) is used to monitor progression, evaluate
response to therapy and predict recurrence of hepatocellular carcinoma (HCC) in liver …

Background Liver transplantation (LT) offers a possible cure for carefully selected patients
with hepatocellular carcinoma (HCC). Studies report that preoperative alpha‐fetoprotein …

OBJECTIVES To assess, in a large multi-centric survey, diagnostic and prognostic reliability
of AFP, predictive factors, and any correlation with the tumor immunophenotype. METHODS …

Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, is
known for its grim prognosis, with untreated life expectancy being only a matter of months …

Purpose Alpha-fetoprotein (AFP) is considered to be an indicator of tumor activity in
hepatocellular carcinoma (HCC). We present a novel correlation of AFP response to …